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Abstract: 
Background: Human herpesvirus-8 (HHV-8) is an opportunistic virus proved to be the cause of 
AIDS associated Kaposi’s sarcoma. Based on the emergence of HIV and its pandemic spread HHV-
8 is expected to participate in increasing the risk of Kaposi’s sarcoma in areas where the rate of 
infection is high. There is a great need to study the epidemiology of the virus.  
Objectives: To find out the rate of infection with HHV-8 in Khartoum among blood donors and 
post-kidney transplant patients 
Methodology: Venous blood samples were collected from 90 Subjects (60 blood donors from 
Elsalam Cardiac Centre (controls) and 30 kidney transplanted patients from IbnSina hospital). The 
blood specimens were tested for Human herpes virus anti- IgG using ELISA technique. 
Results: The overall rate of infection with HHV-8 was found to be 2.2%. The highest rate of 
infection (20%) was in the age group 46 years and more. The seroprevalence of HHV-8 was found 
to be 6.7% in post-kidney transplant patients. None of the control group proved to be positive for 
HHV-8. 
Conclusion: The rate of infection with HHV-8 was found to be relatively lower in the studied 
group. 
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uman herpes virus type 8 is a herpes 
virus that belongs to the subfamily 
gamma herpesvirinae of the family 
herpesviridae. As early as 1994 scientists 
reported that, they had detected herpes like 
structure in Kaposi’s sarcoma (KS) tumor by 
electron microscope 1. They had then started 
searching the causative agent of Kaposi’s 
sarcoma among more than 20 agents 
described as the possible causes; among these 
were cytomegalovirus and HIV1. Chang and 
Moore could successfully sequence the entire 
genomeof a herpes viruswhich proved to be 
the causative agent of Kaposi’s sarcoma2.
That virus is known now as human 
herpesvirus typein sub-Saharan Africa, 
intermediate levels of infection occur in 
Mediterranean countries and low levels of 
infection in most North European 
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and North American populations. The virus is 
opportunistic.Although it is wide spread it 
only causes tumor in immune-compromised 
patients as AIDS patients. With the global 
epidemic of HIV infection causing 
immunodeficiency; increasing incidence of 
Kaposi’s sarcoma is anticipated. There is 
therefore a great need to study the 
epidemiology of the virus so that appropriate 
control measures will be taken for reducing 
the transmission of the virus and hence the 
incidence of Kaposi’s sarcoma. 
Objective: 
To find out the rate of infection with HHV-8, 
in Khartoum among blood donors, and post-
kidney transplant patients. 
Materials and methods: 
A total of 90 participants were recruited in 
this study. Sixty of them were blood donors in 
Elsalam Centre for Cardiac Surgery (healthy 
controls) and30 post-kidney transplant 
patients attending IbnSina hospital for follow 
up (immune-compromised individuals). 
Fromeach subject 3 mls of venous blood were 
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collected into sterile, clean and dry plain 
container. The collected blood specimens 
were allowed to clot.After clot retraction the 
sera were separated by centrifugation and 
stored in a deepfreezer at – 20o C until tested. 
The stored sera were examined for human 
herpes virus type 8 IgG antibodies using 
ELISA technique. The test procedure 
involved three incubation steps: 
Thetest sera, positive (in duplicate) and 
negative control sera were added into the 
corresponding wells of micro titer plate 
coated with optimal amount of solubilized 
HHV-8 whole virus extract. One well was left 
as blank. Specific HHV-8 antibodies present 
in the serum bound to the antigen-coated 
plates forming Ag/Ab complexes. After 
incubation the strips were washed to remove 
unbound samples components. Antihuman 
IgG conjugated to enzyme horseradish 
peroxidase (HRP) was added to the wells and 
during incubation bound to the Ag/Ab 
complexes already formed in the micro wells. 
After other incubation the micro wells were 
washed to remove unbound conjugate. HRP 
substrate tetramethylbenzedine (TMB) was 
added to the wells. During incubation, 
enzyme mediated cleavage of the substrate 
resulted in a color change. The reaction was 
then stopped using stop solution. The optical 
densities (OD) of specimens and control were 
readwithin 30 minutes using 
spectrophotometer (ELISA reader) at 
wavelength 450 nm.The test procedure was 
then validated according to the manufacturer 
instruction as follows: 
OD of the blank≥ 0.100. 
OD of positive control at least 1.5 times of the 
cutoff serum. 
The ratio between OD ofnegative control and 
cutoff serum must be≥ 0.6. 
The absorbance of the cutoff must be < 0.2. 
Calculation of the cutoff value: 
The cutoff value was calculated according to 
the formula: Cutoff value =1,227 x 0.10 (= 
0.123) Where 1,227 was the mean of the OD 
of the two positive control sera. 
Interpretation of the results: 
Specimens with OD less than the cutoff value 
were considered to be negative. Those with 
cutoff values greater or equal to the cutoff 
were considered positive. 
Results: 
A total of 2(2.2%) were found to be positive 
for HHV-8 IgG antibodies. The two positive 
cases were both post-kidney transplant 
patients giving seroprevalence of 6.7% in this 
group. None of the control group was found 
to be positive. The positive cases constituted 
20 % of the age group 46 years and more 
(table 1),they were both kidney transplanted 7 
-12 months before testing (table 2). 
Table 1: Distribution of HHV anti IgG 












15 – 25 21 0 0 
25 – 35 40 0 0 
36 – 45 19 0 0 
46 ≤ 10 2 20
Total 90 2 2.2 
Table 2: Distribution of HHV-8 IgG 
amongpost-kidney transplant patients 











1 – 6 21 0 0
7 – 12 7 2 28.5
13 – 19 0 0 0 
20 – 24 2 0 0 
Total 30 2 6.7 
Discussion: 
The overall seroprevalence of HHV-8 IgG 
antibodies among the studied group of blood 
donors and post-kidney transplant patients 
was found to be 2.2%. This figure is 
comparable with previous studies done in 
USA and Northern Europe (5-10% & 5% 
respectively) 3, 4.
None of the blood donors was found to be
Kafi  et al.               Human herepes virus among blood donors and post-kidney transplant patients 
© Sudan JMS Vol. 8, No.1. Mar 2013 37 
 positive for HHV-8 which is in disagreement 
with previous reported figures from Belgium 
and China (3.3% and 20.4%, respectively)5, 6.
This variation in the rate of infection with 
HHV-8 can be attributed to the different 
socioeconomic conditions and the small 
sample size in the current study. 
In Greece,Azavitsanou and his colleagues 
reported seroprevalence of HHV-8 of 7.2% 
among patients on haemodialysis7.He also 
reported that patients younger than 50 years 
had an increased probability for HHV-8 
infection.  
Conclusion: 
The rate of infection with Human herpesvirus 
type 8is 6.7% among the studied group of 
post-kidney transplant patients and zero% 
among the control group of blood donors. The 
rate of infection was found to be higher (20%) 
after the age of 46 years. Further in depth 
studies including different populations and 
larger sample size are needed to validate these 
results. 
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